Consolidated Statements of Income - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Net sales	$ 15,664	$ 13,885	$ 30,928	$ 25,767
Cost of sales	12,899	10,740	25,301	20,802
Research and development expenses	217	228	435	422
Selling, general and administrative expenses	435	440	933	806
Amortization of intangibles	85	100	173	201
Restructuring and asset related charges - net	0	22	186	22
Equity in earnings of nonconsolidated affiliates	195	278	369	502
Sundry income (expense) - net	75	(3)	223	125
Interest income	36	13	64	21
Interest expense and amortization of debt discount	165	187	332	383
Income before income taxes	2,169	2,456	4,224	3,779
Provision for income taxes	488	524	991	841
Net income	1,681	1,932	3,233	2,938
Net income attributable to noncontrolling interests	20	31	3	46
Net income available for The Dow Chemical Company common stockholder	1,661	1,901	3,230	2,892
The Dow Chemical Company
Net sales	15,664	13,885	30,928	25,767
Cost of sales	12,899	10,739	25,297	20,800
Research and development expenses	217	228	435	422
Selling, general and administrative expenses	434	440	932	806
Amortization of intangibles	85	100	173	201
Restructuring and asset related charges - net	0	22	186	22
Equity in earnings of nonconsolidated affiliates	195	278	369	502
Sundry income (expense) - net	78	6	214	125
Interest income	38	13	66	21
Interest expense and amortization of debt discount	165	187	332	383
Income before income taxes	2,175	2,466	4,222	3,781
Provision for income taxes	488	521	991	838
Net income	1,687	1,945	3,231	2,943
Net income attributable to noncontrolling interests	20	31	3	46
Net income available for The Dow Chemical Company common stockholder	$ 1,667	$ 1,914	$ 3,228	$ 2,897